InMed Pharmaceuticals Inc (INM)

[T-Tucker]

Important message in regard to past week.

We have received a considerable amount of emails over the last few days regarding this event, selling of Insider holdings in InMed. The majority of retail investors consider this a “red flag” and it has obviously triggered a sell signal amongst the investor community. Although I am not privy to why some of the Insiders have decided to sell ,I can however confirm they have an unwavering commitment to InMed and strongly believe in the company. The recent disposition of holdings of Board and Management represent less than 5% of their total holdings. InMed through its recent financing is in a stronger position than it has been through its evolution from a pre-clinical company and as it transition into a clinical stage company in 2018.

The team at InMed is committed to regaining investor confidence and executing on the business objectives/milestones in 2018 that we believe will continue to create shareholder value. Your continued support and belief in our Company is very much appreciated. I am available for a call at the number below if you would like to talk further.

Best Regards
Chris Bogart